Katherine Mcleod, the CEO of First Choice Primary Care, says there’s currently a doctor and nurse practitioner seeing ...

Novo Nordisk A/S rose the most since August 2023 after its experimental shot delivered as much as 22% weight loss in an early-stage trial. Madison Muller has more on Bloomberg Television.